Puma Biotechnology falls more than 20%
Puma Biotech In-Licenses Takeda's Cancer Candidate With Primary Focus On Breast & Lung Cancer
Why Puma Biotechnology Is Soaring Today | The Motley Fool
Supernus, Puma Among 5 Big Biotech Stock Winners, Losers Monday | Stock News & Stock Market Analysis - IBD
PBYI | Puma Biotechnology Inc. Stock Overview (U.S.: Nasdaq) | Barron's
Articles with Puma Biotechnology
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Puma Biotechnology: Risky Investment (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology Inc (PBYI) Stock: Do Analysts Think You Should Sell?
With 53% institutional ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) is a favorite amongst the big guns | Nasdaq
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
Puma Biotechnology Inc (PBYI) Stock: Do Analysts Think You Should Sell?
PBYI Stock Forecast, Price & News (Puma Biotechnology)
Stocks to Watch: Dropbox, Nike, Tronc, Qualcomm, Puma Biotechnology, Invitation Homes, Universal Display - WSJ
Puma Biotech (PBYI) Stock up as Q2 Earnings & Sales Beat
Puma Biotechnology
Why Puma Biotechnology (PBYI) Stock Is Surging Today - TheStreet
Puma Biotechnology up 15% after quarterly earnings beats (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) | citybiz
Puma Biotechnology: A Speculative Investment At A Discount (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology - Crunchbase Company Profile & Funding
Buy Puma Biotechnology Inc stock & View ($PBYI) Share Price on eToro.
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | Business Wire
Is Puma Biotechnology (PBYI) Stock a Solid Choice Right Now?
Puma Biotechnology Inc
Why Puma Biotech Could Get Acquired Between July to September of This Year | BioSpace
